ATE435657T1 - Therapeutische zubereitung von hochreinem fviia und verfahren zu dessen gewinnung - Google Patents

Therapeutische zubereitung von hochreinem fviia und verfahren zu dessen gewinnung

Info

Publication number
ATE435657T1
ATE435657T1 AT07380021T AT07380021T ATE435657T1 AT E435657 T1 ATE435657 T1 AT E435657T1 AT 07380021 T AT07380021 T AT 07380021T AT 07380021 T AT07380021 T AT 07380021T AT E435657 T1 ATE435657 T1 AT E435657T1
Authority
AT
Austria
Prior art keywords
fviia
obtaining
therapeutic preparation
highly pure
preparation
Prior art date
Application number
AT07380021T
Other languages
English (en)
Inventor
Gamon Salvador Grancha
Debart Pere Ristol
Nieto Juan Ignacio Jorquera
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36676691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE435657(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Application granted granted Critical
Publication of ATE435657T1 publication Critical patent/ATE435657T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT07380021T 2006-02-17 2007-02-05 Therapeutische zubereitung von hochreinem fviia und verfahren zu dessen gewinnung ATE435657T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200600373A ES2257225B1 (es) 2006-02-17 2006-02-17 Preparacion terapeutica de fviia de muy alta pureza y metodo para su obtencion.

Publications (1)

Publication Number Publication Date
ATE435657T1 true ATE435657T1 (de) 2009-07-15

Family

ID=36676691

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07380021T ATE435657T1 (de) 2006-02-17 2007-02-05 Therapeutische zubereitung von hochreinem fviia und verfahren zu dessen gewinnung

Country Status (8)

Country Link
US (1) US7531513B2 (de)
EP (1) EP1820509B1 (de)
JP (1) JP5196799B2 (de)
AT (1) ATE435657T1 (de)
DE (1) DE602007001467D1 (de)
ES (2) ES2257225B1 (de)
PL (1) PL1820509T3 (de)
PT (1) PT1820509E (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2549074T3 (es) * 2008-05-30 2015-10-22 Novo Nordisk Health Care Ag Método de control de una reacción de modificación de polipéptidos
WO2011024962A1 (ja) * 2009-08-28 2011-03-03 財団法人先端医療振興財団 肝臓関連疾患治療薬
EP2652491B1 (de) 2010-12-15 2017-11-29 Baxalta GmbH Eluatsammlung mit leitfähigkeitsgradient
EP3426265B1 (de) 2016-04-28 2021-09-22 Alkahest, Inc. Plasmafraktionen als therapie von tumorwachstum und -progression
IL304946A (en) 2016-08-18 2023-10-01 Alkahest Inc Blood plasma fractions as a treatment for cognitive disorders associated with aging
BR112019022402A2 (pt) 2017-04-26 2020-05-19 Alkahest Inc regime de dosagem para tratamento de comprometimentos cognitivo e motor com plasma sanguíneo e produtos de plasma sanguíneo
WO2020018343A1 (en) 2018-07-20 2020-01-23 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
MX2021004755A (es) 2018-10-26 2021-06-08 Alkahest Inc Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrizacion de heridas y la recuperacion posoperatoria.
WO2021091855A1 (en) 2019-11-04 2021-05-14 Alkahest, Inc. Blood plasma fractions for use in muscle regeneration
US11660316B2 (en) 2019-11-20 2023-05-30 Alkahest, Inc. Methods of inducing liver regeneration by administering a plasma protein fraction
JP2026511640A (ja) 2023-03-29 2026-04-14 グリフォルス・ワールドワイド・オペレーションズ・リミテッド ＦｃεＲＩβ自己抗体のレベルが低減された血漿製剤の組成物および調製方法
WO2025230830A1 (en) 2024-04-29 2025-11-06 Alkahest, Inc. Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US4470969A (en) * 1983-12-02 1984-09-11 Miles Laboratories, Inc. Process for producing a concentrate of coagulation factors VII and VIIa
FR2632524B1 (fr) * 1988-06-09 1992-03-13 Fondation Nale Transfusion San Procede de preparation d'une fraction concentree en facteur viia et son application a titre de medicament
FR2684999A1 (fr) * 1991-12-16 1993-06-18 Aquitaine Dev Transf Sanguine Procede de fabrication d'un concentre de facteur vii active de haute purete essentiellement depourvu des facteurs vitamine k dependants et des facteurs viiic et viiicag.
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
US6310183B1 (en) * 1997-09-10 2001-10-30 Novo Nordisk A/S Coagulation factor VIIa composition
JP2000103800A (ja) * 1998-09-29 2000-04-11 Yoshitomi Pharmaceut Ind Ltd 免疫グロブリンａの精製方法
JP5090605B2 (ja) * 2000-05-03 2012-12-05 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 凝固因子ｖｉｉの皮下投与
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
CN101912601B (zh) * 2002-06-21 2012-08-29 诺和诺德医疗保健公司 因子vii多肽的稳定化固体组合物
EP1713906A2 (de) * 2004-02-03 2006-10-25 Novo Nordisk Health Care AG Keine funktionelle lipid-membran-bindungsdomäne aufweisende koagulationsfaktor vii/viia-varianten
US20070037966A1 (en) * 2004-05-04 2007-02-15 Novo Nordisk A/S Hydrophobic interaction chromatography purification of factor VII polypeptides
EP1778301A2 (de) * 2004-06-29 2007-05-02 Reliance Life Sciences Pvt., Ltd. Verfahren zur verbesserung virensicherer biologischer flüssigkeiten

Also Published As

Publication number Publication date
EP1820509B1 (de) 2009-07-08
ES2257225B1 (es) 2007-03-16
JP5196799B2 (ja) 2013-05-15
US20070197440A1 (en) 2007-08-23
US7531513B2 (en) 2009-05-12
PT1820509E (pt) 2009-09-02
ES2257225A1 (es) 2006-07-16
JP2007217415A (ja) 2007-08-30
DE602007001467D1 (de) 2009-08-20
PL1820509T3 (pl) 2009-12-31
ES2327013T3 (es) 2009-10-22
EP1820509A1 (de) 2007-08-22

Similar Documents

Publication Publication Date Title
DE602007001467D1 (de) Therapeutische Zubereitung von hochreinem FVIIa und Verfahren zu dessen Gewinnung
TW200514790A (en) Bispecific antibody substituting for functional protein
EP2279244A4 (de) Verfahren und zusammensetzungen zur oralen verabreichung von proteinen
CY1108689T1 (el) Ολιγοπεπτιδια για την ελαττωση αυξημενης συγκεντρωσεως της ουριας στο αιμα
MY153198A (en) Inhibitors of protein aggregation
BR0312785A (pt) Tratamento de desordens relacionadas a tnf(alfa)
ATE376559T1 (de) Methoden der verhinderung und behandlung der alzheimer'schen krankheit
DK2316852T3 (da) Stabiliserede enkeltdomæne-antistoffer
EP1505990A4 (de) Verfahren zur behandlung von hepatitis
WO2004083361A3 (en) FVII OR FVIIa VARIANTS
WO2005056585A3 (en) Sars coronavirus s proteins and uses thereof
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
NO20076405L (no) Anvendelse av 24-nor-UDCA
ES2340842T3 (es) Anticuerpos anti-apc no neutralizantes.
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
WO2006114105A8 (en) Use of modified factor vii for treating bleeding
ATE509958T1 (de) Gegen cathepsin s gerichtete therapie
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης
DE602005013650D1 (de) Proteinhydrolysat zur behandlung von müdigkeit
ATE374593T1 (de) Methode zur haarbehandlung gekennzeichnet durch applikation bestimmter 2-hydroxyalkansäuren
EP1796707A4 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
WO2007118849A3 (en) Methods and means for assessing hiv gag/protease inhibitor therapy
ATE374260T1 (de) Asthma-assoziiertes gen
ATE328082T1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
ATE392213T1 (de) Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1820509

Country of ref document: EP